MedTrace Logo

Investigation to Evaluate Performance and Safety of RemovAid ™ in Removal of Contraceptive Implants

NCT03912649 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-02-03

No results posted yet for this study

Summary

The safety and efficacy of a subdermal implant retrieval device (RemovAid) is investigated in a population of 25 women seeking removal of their palpable contraceptive implants.

The primary endpoint of the device is to evaluate the performance of the device, specifically its success rate in removing palpable contraceptive implants. The device shall be able to fixate at least 80% of palpable implants, and successfully remove at least 90% of these implants.

Conditions

  • Removal Contraceptive Implant

Interventions

DEVICE

RemovAid

The RemovAid device is used for removal

Sponsors & Collaborators

  • Karolinska University Hospital

    collaborator OTHER

  • RemovAid AS

    lead INDUSTRY

Principal Investigators

  • Kristina Gemzell-Danielsson, MD, PhD · Karolinska Institutet

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-11
Primary Completion
2020-11-18
Completion
2020-11-18

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03912649 on ClinicalTrials.gov